Literature DB >> 1911132

Analyzing pulsatile endocrine data in patients with chronic renal failure: a brief review of deconvolution techniques.

J D Veldhuis1, M L Johnson, W K Bolton.   

Abstract

Deconvolution analysis provides an important new technique to evaluate underlying hormone secretory rates quantitatively based upon serially measured plasma hormone concentrations with or without prior knowledge of the half-time of hormone disappearance from the blood. Information about endocrine gland secretion is particularly important in chronic renal failure, wherein the decreased metabolic clearance rates of various hormones would otherwise confound the interpretation of plasma hormone concentrations. Here we review two particularly useful techniques of deconvolution, one of which is a waveform-defined algorithm and the other waveform independent. The first method can be used to estimate both hormone half-life and secretory rates in vivo. The second methodology allows calculation of in vivo hormone secretion rates without assuming any special form for the secretion event, but requires a priori knowledge of hormone half-life. We illustrate examples of these two deconvolution approaches, and discuss why the interpretations of hormone concentration measurements in earlier studies (where deconvolution methods were not employed) must be viewed with caution. Based on such considerations, additional investigations of in vivo hormone secretory pathophysiology will be required in children and adults with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911132     DOI: 10.1007/bf01453694

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations.

Authors:  J D Veldhuis; M L Carlson; M L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 2.  Contemporary tools for the analysis of episodic growth hormone secretion and clearance in vivo.

Authors:  J D Veldhuis; A Faria; M L Vance; W S Evans; M O Thorner; M L Johnson
Journal:  Acta Paediatr Scand Suppl       Date:  1988

Review 3.  Pathophysiological relationships between the biological and immunological activities of luteinizing hormone.

Authors:  M L Dufau; J D Veldhuis
Journal:  Baillieres Clin Endocrinol Metab       Date:  1987-02

4.  Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.

Authors:  J D Veldhuis; W S Evans; L M Demers; M O Thorner; D Wakat; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

5.  Renal extraction, filtration, absorption, and catabolism of growth hormone.

Authors:  V Johnson; T Maack
Journal:  Am J Physiol       Date:  1977-09

6.  Somatomedin inhibitor in uremia.

Authors:  L S Phillips; A C Fusco; T G Unterman; F del Greco
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

7.  Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.

Authors:  J L Borges; R M Blizzard; W S Evans; R Furlanetto; A D Rogol; D L Kaiser; J Rivier; W Vale; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1984-07       Impact factor: 5.958

8.  Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure.

Authors:  G D Sievertsen; V S Lim; C Nakawatase; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

9.  Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats.

Authors:  D Maiter; L E Underwood; M Maes; M L Davenport; J M Ketelslegers
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736

10.  Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump ("Zyklomat")--a new approach to the treatment of infertility in hypothalamic amenorrhea.

Authors:  G Leyendecker; L Wildt; M Hansmann
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

View more
  3 in total

Review 1.  Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.

Authors:  B Tönshoff; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

2.  The effect of hormone therapy on all-cause and cardiovascular mortality in women with chronic kidney disease: protocol for a systematic review and meta-analysis.

Authors:  Sharanya Ramesh; Michelle C Mann; Jayna M Holroyd-Leduc; Stephen B Wilton; Matthew T James; Ellen W Seely; Sofia B Ahmed
Journal:  Syst Rev       Date:  2015-04-08

Review 3.  Male Sexual Dysfunction and Chronic Kidney Disease.

Authors:  Matthew M Edey
Journal:  Front Med (Lausanne)       Date:  2017-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.